Total Funding
86
71
Total FundingPre-Seed raised
Growth Score 86 in past quarter
-3 pts
Heat Score 71 in past quarter
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
82830
PentaBind uses Generative AI and aptamers for innovative drug discovery and diagnostics in biotechnology.
- Miguel Gonzalez Canudas: Chief AI Officer & Co-Founder
- Rory Ryan: CEO & Co-founder
About the Company
PentaBind, shortlisted by Cancer Research UK as New Startup of the Year, is a cutting edge AI aptamer drug discovery firm that recently saved 38 years of manual drug design time, now awaiting imminent results on the next generation of aptamer drugs that have huge applications in cancer and other diseases.